Immediate Impact

23 standout
Sub-graph 1 of 11

Citing Papers

Neoadjuvant Chemoimmunotherapy for NSCLC
2024 Standout
Non-small-cell lung cancer
2024 Standout
3 intermediate papers

Works of Eva E. Schaake being referenced

Timing of Metabolic Response Monitoring During Erlotinib Treatment in Non–Small Cell Lung Cancer
2014
Tumor Response and Toxicity of Neoadjuvant Erlotinib in Patients With Early-Stage Non–Small-Cell Lung Cancer
2012

Author Peers

Author Last Decade Papers Cites
Eva E. Schaake 206 116 56 88 24 306
Neilayan Sen 169 92 85 116 25 335
C. Chira 183 81 37 126 34 313
Shane Mesko 181 94 78 67 36 349
B.A. Jereczek-Fossa 156 87 57 61 21 272
Shingo Toyama 255 84 50 83 22 330
G. Siepe 200 96 33 75 31 281
Karen M. Xu 140 66 54 68 15 269
Durmuş Etiz 185 85 54 115 28 319
Elaine Luterstein 214 82 44 135 16 341
Michael A. Izard 215 106 42 77 19 346

All Works

Loading papers...

Rankless by CCL
2026